Belinda Avalos, MD
b-avalos-md.bsky.social
@ash-hematology.bsky.social President 2025. Professor of medicine and senior advisor to the president of Atrium Health Levine Cancer.
👤 Joined on 02 December 2024
336
Followers
95
Following
2
Total Posts
📜 Kullanıcı Geçmişi
- 02 Ara 2024, 16:27
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@b-avalos-md.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
@ash.hematology.org President @b-avalos-md.bsky.social shares her perspectives on the past year’s political changes and how they are affecting #hematology research and care. bit.ly/474ugkS
Show Post
🟣🟣🟣 Check out this straightforward method of improving human hematopoietic stem cell expansion by inhibiting ferroptosis 🟣🟣🟣 thanks for including me @bloodgenes.bsky.social #hemesky 🧬🔬🧪
Show Post
Dr. Oyedeji’s #NIH-funded SCD study was cut midway. Such funding cuts not only disrupt patient care but also may discourage researchers, particularly those from underrepresented backgrounds. Learn more: https://ow.ly/aYaV50XKqQU #Fight4Hematology #ResearchSavesLives #SickleCell #HemeSky
Show PostDr. Livingstone’s experience in the ASH VTP highlights how training hematologists worldwide strengthens labs for #SickleCell, #Hemophilia, and other blood disorders. 🌍 Support this global impact and make your year end gift: https://ow.ly/qRlZ50XKzWk #HemeSky #MedSky
Show Post📢 ASH is now accepting public comments on the new guidelines on dosing and monitoring of Hydroxyurea for SCD. Submit your comments by January 20, 2026. 🔗 https://www.hematology.org/education/clinicians/guidelines-and-quality-care/public-comment-guidelines #ConquerSCD #HemeSky #MedSky
Show Post